What is COLL's P/E ratio?

COLLEGIUM PHARMACEUTICAL INC (COLL) currently trades at a P/E ratio of 14.45.

COLLEGIUM PHARMACEUTICAL INC reports a Return on Equity (ROE) of 23.99%.

What is COLL's dividend yield?

COLLEGIUM PHARMACEUTICAL INC offers a dividend yield of 0.00%.

What is COLL's Deepscope Quality Score?

Deepscope rates COLL's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy COLL?

Deepscope's AI Timing Score for COLL is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does COLL belong to?

COLLEGIUM PHARMACEUTICAL INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.

COLL (NASDAQ) 株価分析 | COLLEGIUM PHARMACEUTICAL INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

COLL

COLLEGIUM PHARMACEUTICAL INC

USD 33.38

0.69 (2.11%) Day Change

Watchlist Portfolio Compare Chart

14.45

P/E

2.57

D/E

24.0%

ROE

4.5%

ROA

0.00%

Div Yield

-0.20

PEG

COLLEGIUM PHARMACEUTICAL INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 33.38 Price 0.69 (2.11%) Day Change	NEWS SCORE: 89

COLL, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	1415
Magic Formula Rank by ROE	1415
Magic Formula Rank by ROIC	777
Price	33.38
PBV / Sector	3.47 / 2.76
Earning Per Share	2.31

PE / Sector	14.45 / 23.64
PEG or PE/Growth / Sector	-0.20 / 0.13
Average 1M Daily Value	13.84 M GREAT
Average 1W Daily Value	14.79 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

66%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	9.41 / 15.98
NPM Average (%) / Sector	6.31 / -16.38
NPM Change Average (%) / Sector	-59.58 / 113.39
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	4.54 / 8.16
ROA Average (%) / Sector	2.91 / 2.38
ROA Change Average (%) / Sector	-72.06 / 108.63
ROE (%) / Sector	23.99 / -0.19 GOOD
ROE Average (%) / Sector	17.37 / 7.40
ROE Change Average (%) / Sector	-71.32 / 371.95
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.53
Dividend Average (%) / Sector	N/A / 3.08
Dividend Change Average (%) / Sector	N/A / 14.88

登録情報

Analyze Date	2026-06-06 09:09:09
Symbol	COLL
Name	COLLEGIUM PHARMACEUTICAL INC
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	32.43 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,082.64 / 9,835.56

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072

Phone: 781 713 3699

Website: https://www.collegiumpharma.com

Employees: 423

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.